A Matched Intervention Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
Phase of Trial: Phase 0
Latest Information Update: 11 Sep 2019
Price : $35 *
At a glance
- Drugs Eculizumab (Primary)
- Indications Liver injury
- Focus Therapeutic Use
- 20 Feb 2019 Planned initiation date (Estimated date of first participant enrollement) changed from 1 Feb 2019 to 1 Mar 2019.
- 20 Feb 2019 Status changed from not yet recruiting to recruiting.
- 08 Jan 2019 Planned initiation date changed from 15 Nov 2018 to 1 Feb 2019.